BAY-299 free base · Synonyms: BAY 299 · BAY299

BAY-299 is a very potent, dual inhibitor.

For research use only. Not for human or veterinary use.

Target Epigenetic Reader Domain

Research area Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

BAY-299 structure

CAS No.: 2080306-23-4

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
100 mg	USD 380.00	BP-01967-100mg	In stock	Get quote
250 mg	USD 650.00	BP-01967-250mg	In stock	Get quote
500 mg	USD 1,050.00	BP-01967-500mg	In stock	Get quote
1 g	USD 1,550.00	BP-01967-1g	In stock	Get quote
5 g	Inquire	BP-01967-5g	Inquire	Inquire

Need another size or custom synthesis? Request a quote.

Description

BAY-299 is a very potent, dual inhibitor with IC50s of 67 nM for BRPF2 bromodomains (BD), 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2.

Biological activity

In Vitro BAY-299 is a dual inhibitor of the bromodomain and PHD finger (BRPF) family member BRPF2 and the TATA box binding protein-associated factors TAF1 and TAF1L. TR-FRET assays showed that BAY-299 is a potent inhibitor of BRPF2 BD with an IC50 of 67 nM, and a selectivity of 47- and 83-fold over BRPF1 and BRPF3 BDs. The profile of BAY-299 is further confirmed by AlphaScreen assay, where an IC50 of 97 nM and a selectivity of 23- and 25-fold over BRPF1 and BRPF3 BDs are measured. NanoBRET experiments show that the interaction of BRPF2 BD with histones H4 and H3.3 is blocked by BAY-299 with IC50 values of 575 and 825 nM, respectively. For TAF1 BD2, the IC50 values are 970 and 1400 nM, respectively. No inhibitory effect is observed for the interaction between BRPF1 or BRD4 and histone H4 up to 10 μM for BAY-299. BAY-299 inhibits MOLM-13, MV4-11, 769-P, Jurkat, NCI-H526, CHL-1, and 5637 cells proliferation with GI50s of 1060, 2630, 3210, 3900, 6860, 7400, and 7980 nM, respectively. In Vivo Studies of the in vivo pharmacokinetic properties of BAY-299 in rat reveal that blood clearance is low (ca. 17% of hepatic blood flow), volume of distribution in steady-state high, terminal half-life long to very long (t1/2=10 h), and bioavailability high (F=73%). In vivo blood clearance is as anticipated based on rat liver microsome values but lower than expected based on hepatocyte data.

Identifiers

SMILES: CN1C(=O)N(C)C2=CC(N3C(=O)C4=CC=CC5=C4C(=CC=C5CCCO)C3=O)=C(C)C=C12
InChIKey: OFWWWKWUCDUISA-UHFFFAOYSA-N

Specifications

MW (average): 429.4678
Formula: C₂₅H₂₃N₃O₄
CAS No.: 2080306-23-4
Physical state: Solid
Color: light yellow to yellow
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

Documents

References

[1]. Bouché L, et al. Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains. J Med Chem. 2017 May 11;60(9):4002-4022.

Same target

Search Epigenetic Reader Domain

Same research area

Search Cancer